Abstract
Human skin absorption of radiolabeled parathion was studied in vitro at specific doses (mass loadings) of 0.4, 4.0, 41, or 117 μg/cm2, with and without occlusion. The compound was applied in small volumes of acetone solution to split-thickness skin. Permeation of radiolabel into the receptor solutions was monitored for 76 h, after which the tissue was dissected and analyzed for residual radioactivity. For the 3 lower doses, cumulative permeation after 76 h was approximately dose-proportional, ranging from 28.5–30.5% of applied dose (unoccluded) to 45.5–55.7% (occluded). Total absorption, calculated as receptor fluid plus dermis content, followed a similar pattern. Both permeation rate and total absorption continued to increase up to the highest dose tested, consistent with results from other laboratories. These results are compared with predictions from a previously developed skin diffusion model (CitationKasting et al., 2008a). The model predicted total absorption to within a factor of 1.4 at 0.4 μg/cm2 and 1.6 at 4 μg/cm2, but substantially underpredicted absorption at the 2 higher doses. The analysis showed that parathion partitioned more favorably into the stratum corneum than the diffusion model prediction. Nevertheless, comparison of the model predictions to a previously reported human study showed that the skin absorption model, when corrected for surface losses occurring in vivo, satisfactorily described in vivo dermal absorption of parathion applied at 4 μg/cm2 to various body sites.
Acknowledgments
We acknowledge a helpful conversation with Dr. John Kissel. Financial support for this study was provided by NIOSH/CDC grant R01 OH007529. The conclusions reached represent the opinions of the authors and have not been endorsed by NIOSH.